Primary Breast Cancer ER+ve
1 competing product in clinical development for Primary Breast Cancer ER+ve.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Enzalutamide + Exemestane | Astellas Pharma | Phase 2 | Completed | 35 |
1 competing product in clinical development for Primary Breast Cancer ER+ve.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Enzalutamide + Exemestane | Astellas Pharma | Phase 2 | Completed | 35 |